Gliolan - direct healthcare professional communication (DHPC)

5-aminolevulinic acid hydrochloride

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Important information on Gliolan (5-aminolevulinic acid, 5-ALA): What to do in case of delayed surgery and information on fluorescence in non high-grade glioma

Key facts

• Medicine name:
  Gliolan
• Active substance:
  5-aminolevulinic acid hydrochloride
• Therapeutic area (MeSH):
  Glioma
• Procedure number:
  EMEA/H/C/000744/II/0018/G
• Regulatory outcome:
  Variation
• DHPC type:
  Type II variation
• Human ATC codes:
  L01XD04
• Dissemination date:
  01/12/2020